… thrombosis is indeed prevalent in COVID-19, (b) reviewing data supporting and refuting the
role of thrombosis as a contributor to COVID-19 … mechanisms of thrombosis seen in related …

… and coagulopathy in patients who die from COVID-19. Furthermore, the hypoxia that occurs
in severe COVID-19 can aggravate thrombosis not only by increasing the viscosity of the …

… COVID-19. Given thrombotic complications are central determinants of the high mortality rate
in COVID-19, strategies to prevent thrombosis … to prevent COVID-19-associated thrombosis, …

… vessels in patients with Covid-19 showed widespread thrombosis with microangiopathy. …
with Covid-19 as in patients with influenza (P<0.001). In lungs from patients with Covid-19, the …

… as pulmonary embolism and MI, should use methods validated for patients without COVID-19. …
Patients with COVID-19 diagnosed with arterial or venous thrombosis should be treated …

… thrombosis, even in patients receiving prophylactic anticoagulation. The predilection for
thrombosis in COVID-19 … COVID-19 pulmonary thrombosis and thromboembolism are discussed. …

… a significant risk of thrombosis in patients with COVID-19. A … thromboembolic events in 184
COVID-19 ICU patients, despite … included pulmonary embolism (PE), deep-vein thrombosis (…

… One obvious question is whether these rates of thrombosis are higher than we would … -COVID-19
ICU population and report 3–6 times the expected rates of thrombosis in the COVID-19 …

… in critically ill COVID-19 patients in … COVID-19. Second, with anticoagulant thromboprophylaxis,
the authors report a rate of major bleeding of 5.6% in critically ill patients with COVID-19 …

… The results of this study showed an elevated risk of pulmonary embolism in patients with
COVID-19 induced ARDS compared to a population of patients with ARDS from other causes. …